In the past 10 years, there has been incredible progress in CRISPR thanks to enormous private and public investment. But, what should we expect ahead? Gusui Wu, Head of Seeds Research at Syngenta, tackled in his presentation at World Agri-Tech in San Francisco, March 20th. He pointed out, at scale delivery of gene-edited products hasn’t yet occurred.